Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

VISX Wins FDA Approval for Treatment of Hyperopic Astigmatism
Oct 2000
SANTA CLARA, Calif., Oct. 23 -- The US Food and Drug Administration has deemed VISX Inc.'s STAR excimer laser systems as safe and effective for the treatment of hyperopic astigmatism. VISX develops refractive laser technology for the US and other countries. : We are extremely pleased to add another FDA-approved indication to our product offering, said Liz Davila, president and COO of VISX. The ability to treat hyperopic astigmatism on the VISX STAR laser systems will benefit our customers and their patients.

News & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.